Suggestions
Brian Best
Biotechnology Executive & Advisor
Professional Background
Brian Best is a highly accomplished professional with over 25 years of operational experience within the pharmaceutical, medical device, and diagnostic industries. His career has been distinguished by his extensive leadership roles across both large and small organizations. Throughout his career, Brian has honed his expertise in various clinical and commercial platforms, positioning himself as a specialist in building robust commercial, clinical, and medical affairs functions. He emphasizes the significance of alignment, cadence, and objectives-focused performance within organizations, contributing greatly to their success.
In his current role as the Chief Executive Officer at Predigen, a pioneering precision medicine start-up associated with Duke University, Brian is leveraging innovative host gene expression technology to predict and manage health and disease. This role showcases his commitment to advancing healthcare through cutting-edge research and technology, ultimately leading better health outcomes.
Moreover, Brian is the founder of Ariste Medical, a commercial-stage company dedicated to developing drug-eluting implantable medical devices that can have a transformative impact on patient care. Additionally, he serves as the President of BestBio Consulting, where he provides strategic advisory services to senior management teams across various healthcare markets. His wealth of experience makes him a sought-after consultant and advisor in the industry.
Education and Achievements
Brian Best's educational background is as impressive as his professional journey. He studied at Wake Forest University, where he obtained a Bachelor of Science (BS) degree in Business. Following this, he advanced his education by specializing in Biotechnology Management at The Wharton School, a prestigious institution known for nurturing business leaders. He further developed his expertise in Pharmaceutical Marketing at UCLA Anderson School of Management. This strong educational foundation has equipped Brian with the critical knowledge and skills necessary to excel in the highly competitive healthcare industry.
Notable Achievements
Brian Best has played a pivotal role in a variety of noteworthy organizations throughout his career. He co-founded and served as CEO at Predigen Inc, driving innovations in precision medicine. He was also a significant leader at BestBio Consulting, where he made impactful contributions as the President. His prior roles have included Chief Business Officer at Childhood Arthritis and Rheumatology Research Alliance (CARRA) Inc., as well as Director of Life Sciences Consulting at Navigant. Brian has held various positions at Tethys Bioscience, where he rose to become Senior Vice President of Marketing and Medical Affairs, as well as Vice President of Commercial Operations.
His impressive history also includes serving as Vice President of Sales and Marketing at Medicure, and providing consultancy services to high-profile organizations like PDL Biopharma and Portola Pharmaceuticals. His leadership capabilities were honed during his time at Millennium Pharmaceuticals, where he held multiple key positions such as Director of Marketing and Medical Affairs.
Brian is also recognized for his work in clinical affairs and medical affairs, ensuring that both the commercial and clinical strategies are robust and aligned with the overarching objectives of the organizations he works with. His strong background in registry and study design development, along with expertise in business development, licensing, and acquisition, makes him an invaluable asset in the field.
Conclusion
Overall, Brian Best exemplifies the ideal blend of strategic foresight, extensive industry knowledge, and a passion for advancing healthcare. With a solid foundation in education and decades of practical experience, he continues to shape the future of the pharmaceutical and medical device industries. His leadership in precision medicine and contributions through various organizations highlight his dedication to improving global health through innovation and strategic excellence.
title
